Vimeo
LinkedIn
Instagram
Share |

medtech

Introducing the medical device that is a “game changer” in the future of digital health
May 24, 2023

The traditional stethoscope has not been improved upon for more than 200 years, but now M3DICINE, an innovative MedTech firm is introducing game-changing devices (according to the Mayo Clinic) that could see healthcare professionals forever shifting how vital sign examinations are done.

The traditional stethoscope has not been improved upon for more than 200 years, but now M3DICINE, an innovative MedTech firm is introducing game-changing devices (according to the Mayo Clinic) that could see healthcare professionals forever shifting how vital sign examinations are done.

Harnessing opportunities in healthcare
April 11, 2023

In a new report, private markets experts Titanbay discuss why they believe specialist investors with deep domain knowledge and industry expertise are best placed to support the development of healthcare solutions of the future.

Healthcare is one of the largest and fastest-growing global industries and it has the power to transform living standards. Private equity firms have played an active role in the global healthcare sector for decades and it continues to provide a large and growing opportunity set for investment. The global healthcare market is estimated to expand to $9.9 trillion by 2030 and $14.4 trillion by 2050.

Introducing the unique medical group ethically healing thousands of patients
November 16, 2022

Wellbeing International Foundation, headed by successful entrepreneur Max Lewinsohn, helps your body to heal itself by infusing billions of your own extracellular vesicles, generated from your own stem cells via a simple non-intrusive process. 

Back in 2010, successful multi-disciplinary business leader Max Lewinsohn was suffering from a knee injury caused by multiple sports injuries over the years. Having tried numerous solutions, he sceptically turned to Wellbeing International Foundation and was so impressed with the results that he joined the board as chairman following a reorganisation in 2016.

Further innovations in MedTech to be presented at the 32nd MTi Forum
July 6, 2022

Companies developing pioneering oesophageal drug-delivery systems, innovative bio-wearables and a venture builder for MedTech and biotech advances will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

Companies developing pioneering oesophageal drug-delivery systems, innovative bio-wearables and a venture builder for MedTech and biotech advances will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

Innovations in MedTech to be presented at the 32nd MTi Forum
June 9, 2022

Companies developing complex disease-solving data curation, heart-failure telemonitoring and home sperm testing will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

Companies developing complex disease-solving data curation, heart-failure telemonitoringand home sperm testing will exclusively present in-person as Campden Wealth returns to Lausanne, Switzerland, for the 32nd edition of the MedTech Investing Europe Forum (MTi) on July 12 and 13.

The disruptive medtech company aiming to minimise patients’ need for invasive mechanical ventilation intervention
April 4, 2022

INSPIRA is developing a cost-effective respiratory support system which will function as an artificial lung for deteriorating respiratory patients. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, president and co-founder Joe Hayon explains the benefits and potential future applications of the system.

INSPIRA is an innovative medical device company which is developing the ART system, a cost-effective early extracorporeal respiratory support system which will function as an artificial lung for deteriorating respiratory patients.

The ART system utilises a new approach based on hemo-protective technology aimed at rebalancing oxygen saturation levels while patients are awake and breathing, potentially minimising the patient's need for invasive mechanical ventilation intervention.

The disruptive tech firm aiming to reduce the need for cataract surgery
March 31, 2022

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum, chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Using a new light-based non-surgical treatment, this cutting-edge treatment has already proved effective in clinical trials.

Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, Edinburgh Biosciences’ chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

Fearless entrepreneur: Werner Tschollar on breakthroughs in biotech and staying small and flexible in business
February 16, 2022

For nearly three decades, Dr. Werner Tschollar has been at the forefront of the pharmaceutical, biotech and financing industries. With a humanitarian approach to life and a savvy head for business, he has parlayed his extensive credentials and experience into a series of innovative products and treatments that have changed the quality of life for countless people.

For nearly three decades, Dr. Werner Tschollar has been at the forefront of the pharmaceutical, biotech and financing industries. With a humanitarian approach to life and a savvy head for business, he has parlayed his extensive credentials and experience into a series of innovative products and treatments that have changed the quality of life for countless people.

A deep dive into deep tech
September 30, 2021

Deep tech is much talked about by governments, and the European Commission especially, but often without an explanation of what it actually is. Only by defining, and therefore assessing, its character can we consider its place in the European startup ecosystem.

Deep tech is much talked about by governments, and the European Commission especially, but often without an explanation of what it actually is. Only by defining, and therefore assessing, its character can we consider its place in the European startup ecosystem.

Stephen Nundy, partner at Lakestar, and Yoram Wijngaarde, founder and chief executive of Dealroom, in conversation about the future of deep tech and its role in Europe’s future.

The EU Medical Devices and IVD Regulations—past, present and future
September 22, 2021

The European Union’s regulation of medical devices in Europe only began in the 1990s. Previously, member states acted independently, but the differing national requirements were replaced by EU directives including the 1993 Medical Devices Directive (MDD) and the 1998 In Vitro Diagnostics Directive (IVDD). 

The European Union’s regulation of medical devices in Europe only began in the 1990s. Previously, member states acted independently, but the differing national requirements were replaced by EU directives including the 1993 Medical Devices Directive (MDD) and the 1998 In Vitro Diagnostics Directive (IVDD).

Click here >>
Close